ArticleCancers2022

Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and Trametinib.

Gregoire Mondielli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.